HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SC 56631

structure in first source

Also Known As:

SC-56631; beta-(2-((5-((aminoiminomethyl)amino)-1-oxopentyl)amino)-1-oxoethyl)amino-3-pyridine propanoic acid, bistrifluoroacetate

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - SC 56631: 1

Experts

1.	Carron, C P: 1 article (06/2000)
2.	Engleman, V W: 1 article (06/2000)
3.	Meyer, D M: 1 article (06/2000)
4.	Nickols, G A: 1 article (06/2000)
5.	Ornberg, R L: 1 article (06/2000)
6.	Rico, J G: 1 article (06/2000)
7.	Ruminski, P G: 1 article (06/2000)
8.	Westlin, W F: 1 article (06/2000)

Related Diseases

1.

Bone Resorption

06/01/2000 - "SC-56631 and SC-65811 blocked osteoclast-mediated bone resorption in a dose-responsive manner. "
06/01/2000 - "In this study, we characterized the effects of two synthetic peptidomimetic antagonists of alpha v beta 3, SC-56631 and SC-65811, on rabbit osteoclast adhesion to purified matrix proteins and bone, and on bone resorption in vitro. "
06/01/2000 - "Surprisingly, however, osteoclasts treated with SC-65811, SC-56631 or the disintegrin echistatin, at concentrations that inhibit bone resorption did not inhibit osteoclast adhesion to bone. "

Related Drugs and Biologics

1.	Peptidomimetics
2.	Proteins (Proteins, Gene)
3.	SC 65811
4.	Disintegrins
5.	echistatin